Navigation Links
Dalton Pharma Services and ProCitius Announce a Strategic Alliance to Provide Contract Chemistry Services

TORONTO, and CHENNAI, India, May 11 /PRNewswire/ -- Dalton Pharma Services and ProCitius Research jointly announce a strategic alliance created to provide clients with contract chemistry services of exceptional value.

Global pharmaceutical companies, in order to maintain their discovery and development output in an era of severe cost restraints, have been increasing their use of "offshore" contract research organizations (CROs) in countries such as China and India. Despite the quality of chemists in offshore CROs, there are often performance issues caused by communication and cultural differences. In order to ensure quality and timeliness in the contracted work, pharmaceutical companies are usually forced to dedicate senior staff to manage these projects on-site or from Western research centers.

Dalton and ProCitius have teamed up to offer clients the best of both worlds. Projects carried out by ProCitius in India are tightly controlled by senior Dalton project managers based at the company headquarters in Canada. Clients deal only with Dalton, which assumes full legal and operational responsibility for the satisfactory execution of the contract. The contract pricing is based on attractive FTE rates.

"I believe this type of hybrid service fills an important need in our industry," said Peter Pekos, President and CEO of Dalton Pharma Services. "Over the past two decades I have worked to adjust our service offering to meet the changing requirements of my clients and today's announcement is part of this continuing evolution," he continued. "In ProCitius we have the ideal partner: well-established; large FTE headcount; excellent facilities and infrastructure; robust documentation; and a reputation for high ethical and environmental standards."

Jeri Raman, VP Business Development of ProCitius Research, remarked, "We are extremely pleased to have established this strategic alliance with Dalton Pharma Services. The reputation of Dalton as a premium CRO in the areas of chemistry and medicinal chemistry makes it the perfect choice for the expansion of our business with the global pharmaceutical industry."

About Dalton Pharma Services

Dalton Chemical Laboratories Inc. o/a Dalton Pharma Services is a Health Canada approved contract pharmaceutical manufacturer that supplies chemistry, medicinal chemistry and analytical services to the biotechnology and pharmaceutical industries in the areas of chemistry, medicinal chemistry, fine chemical manufacture, custom peptides and antisense oligo production. Dalton provides cGMP manufacturing and sterile filling services to its customers at any stage of the regulatory process (Phase I, II, III or commercial). In its state of the art cGMP facilities, Dalton can produce active pharmaceutical ingredients (API), at the gram or kilogram scale. Dalton can carry out sterile fills to produce batches of finished drug product in vials or syringes, either aseptically filled or terminally sterilized, under fully validated conditions. In addition, Dalton's analytical chemistry laboratory offers method development, validation and ICH stability programs to its clients.

About ProCitius Research, a division of Sanmar Speciality Chemicals Ltd.

Sanmar Speciality Chemicals is a member of the Sanmar Group, one of India's most respected business houses. Through its research arm, ProCitius Research, with its state-of-the-art facilities, it offers world class services in contract research and custom synthesis. It has an impressive track record with major pharmaceutical and chemical manufacturers in Europe and the United States of America. More information about the capabilities of Sanmar Speciality Chemicals can be obtained at the website,

    Dalton Pharma Services
    Peter Pekos

    ProCitius Research
    Dr. Bhuvaneswari Sridhar

SOURCE Dalton Pharma Services
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. BioRelix and Dalton Medicinal Chemistry Expand and Renew Research Agreement to Capitalize on Riboswitches
2. Dalton Pharma Services Licenses Thermo Fisher Scientific Technology to Produce Polynucleotides for Drug Development
3. BIKAM and Dalton Medicinal Chemistry Sign Collaborative Research Agreement
4. Dalton Medicinal Chemistry Partners Achieves Another Milestone in Collaboration with Boehringer Ingelheim (Canada) Ltd.
5. BioRelix and Dalton Medicinal Chemistry Sign Research Agreement to Capitalize on RiboSwitch Technology
6. Dalton Medicinal Chemistry Partners Achieves Milestone in Collaboration with Boehringer Ingelheim (Canada) Ltd.
7. Pharmaceutical Packaging Equipment Manufacturer Boosts European Distribution
8. PharmAthene Announces New Date for First Quarter 2009 Conference Call and Webcast
9. Cadence Pharmaceuticals Reports First Quarter 2009 Financial Results
10. PDL BioPharma Announces First Quarter 2009 Financial Results
11. Rib-X Pharmaceuticals Announces Presentations at the 19th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)
Post Your Comments:
(Date:11/25/2015)... SAN DIEGO , Nov. 25, 2015 ... that management will participate in a fireside chat discussion ... New York . The discussion is ... Time. .  A replay will ... Contact:  Media Contact:McDavid Stilwell  , Julie NormartVP, Corporate ...
(Date:11/24/2015)... , Nov. 24, 2015  Asia-Pacific (APAC) ... research organisation (CRO) market. The trend of outsourcing ... lower margins but higher volume share for the ... and scale, however, margins in the CRO industry ... (CRO) Market ( ), finds that ...
(Date:11/24/2015)... SAN DIEGO , Nov. 24, 2015 Halozyme Therapeutics, ... Jaffray Healthcare Conference in New York on ... Dr. Helen Torley , president and CEO, will provide a ... New York at 1:00 p.m. ET/10:00 a.m. ... communication and investor relations, will provide a corporate overview. --> ...
(Date:11/24/2015)... ... 2015 , ... International Society for Pharmaceutical Engineering (ISPE) closed ... events for pharmaceutical manufacturing: 2015 Annual Meeting. The conference took place in Philadelphia, ... number of attendees in more than a decade. , “The 2015 Annual ...
Breaking Biology Technology:
(Date:11/10/2015)... YORK , Nov. 10, 2015 ... to behavioral biometrics that helps to identify and ... fraud. Signature is considered as the secure and ... the identification of a particular individual because each ... more accurate results especially when dynamic signature of ...
(Date:11/2/2015)... Nov. 2, 2015  SRI International has been awarded ... preclinical development services to the National Cancer Institute (NCI) ... provide scientific expertise, modern testing and support facilities, and ... pharmacology and toxicology studies to evaluate potential cancer prevention ... The PREVENT Cancer Drug Development Program is an NCI-supported ...
(Date:10/29/2015)... ANN ARBOR, Mich. , Oct. 29, 2015 ... with Eurofins Genomics for U.S. distribution of its ... DNA-seq kit and Rubicon,s new ThruPLEX Plasma-seq ... DNA to enable the preparation of NGS libraries ... in plasma for diagnostic and prognostic applications in ...
Breaking Biology News(10 mins):